RxSight, Inc. filings document the public-company record for a Nasdaq-listed ophthalmic medical device issuer centered on the RxSight Light Adjustable Lens system. Form 8-K reports furnish operating results, sales guidance, Light Adjustable Lens and Light Delivery Device commercial metrics, preliminary results and other material updates tied to financial condition.
The company’s proxy and governance filings cover annual meeting matters, board and committee composition, executive compensation, equity awards and stockholder voting procedures. Other current reports address officer appointments, transition agreements, compensatory arrangements and the registered common stock structure for RXST.
Form 8-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.70%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.41%
Tags
-
Form 3
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.41%
Tags
Form 8-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.41%
Tags
-
Schedule 13G
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.28%
Tags
-
Form 8-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-37.84%
Tags
FAQ
How many RxSight (RXST) SEC filings are available on StockTitan?
StockTitan tracks 76 SEC filings for RxSight (RXST), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for RxSight (RXST)?
The most recent SEC filing for RxSight (RXST) was filed on August 7, 2025.